China NMPA approves Sanofi’s Sarclisa for patients with newly diagnosed multiple myeloma ineligible for transplant: Paris Saturday, February 1, 2025, 12:00 Hrs [IST] The Nationa ...

European Commission authorises ViiV Healthcare’s long-acting injectable Vocabria plus Rekambys for HIV treatment in adolescents: London, UK Saturday, February 1, 2025, 11:00 Hrs ...

Bayer UK launches new CanesMeno Educational Hub and product range to transform menopause support: Leverkusen Friday, January ...

Chalfont St Giles, UK Saturday, February 1, 2025, 09:00 Hrs [IST] ...

Peethaambaran Kunnathoor, Chennai Saturday, February 1, 2025, 08:00 Hrs [IST] ...

Indian healthcare sees AI and automation to bolster productivity of current workforce: Nandita Vijayasimha, Bengaluru Saturday, February 1, 2025, 08:00 Hrs [IST] Indian healthcare ...

DGTR initiates anti-dumping investigation into imports of MIPA from China: Shardul Nautiyal, Mumbai Saturday, February 1, 2025, 08:00 Hrs [IST] In a significant move to protect th ...

SaSPinjara Life Sciences sees Indian pharma boosting capability in high-demand therapeutics: Nandita Vijayasimha, Bengaluru Saturday, February 1, 2025, 08:00 Hrs [IST] SaSPinjara ...

Amount demanded by NPPA on overcharging cases declines significantly in H1 FY25: Gireesh Babu, New Delhi Saturday, February 1, 2025, 08:00 Hrs [IST] The amount demanded by the dru ...

Renalys Pharma completes patient enrollment in registrational phase III trial of sparsentan for IgA nephropathy in Japan: Tokyo, Japan Friday, January 31, 2025, 18:00 Hrs [IST] Re ...

Strides Pharma Science in its consolidated financial results for the quarter Q3FY25 ended December 31, 2024 reported revenues of Rs. 1,153.7 crore with a growth 14.6% YoY in Q3FY25. The PAT stood at ...

Economic Survey 2025 calls for systematic deregulation, focus on R&D: Our Bureau, New Delhi Friday, January 31, 2025, 15:30 Hrs [IST] Projecting a growth of around 6.3 to 6.8 per ...